Venture NAV Tracker / Private company
Maze Therapeutics, Inc.
Headquarters—
Founded—
Last known round—
Reported valuation—
1 row is omitted from dispersion statistics under the degenerate-mark guard; each affected row states why.
Cross-fund comparison
Current disclosed marks
Included in the same underlying-company comparison band.
| Fund | Security type / annotations | Principal | Fair value | FV / principal | Rate | Maturity | Mark age vs round | Non-accrual |
|---|---|---|---|---|---|---|---|---|
| HTGCHercules Capital, Inc. | senior secured loanFair Value — Senior SecuredNo valuation basis was disclosed for this position. This is an annotation only and does not exclude the mark from comparison statistics.Omitted from statistics — security type is not an eligible fund-equity mark for dispersion. | $28MMar 31, 2026 · source ↗ | $27.8MMar 31, 2026 · source ↗ | 99.2%Mar 31, 2026 · source ↗ | Prime + 0.95 %, Floor rate 7.95 %, 6.45 % Exit FeeMar 31, 2026 · source ↗ | Feb 1, 2031Mar 31, 2026 · source ↗ | —Mar 31, 2026 · source ↗ | NoMar 31, 2026 · source ↗ |
Historical marks
Reported fair value by fund
Each bar is a disclosed position-quarter.